260 related articles for article (PubMed ID: 14709553)
21. Unification of the copper(I) binding affinities of the metallo-chaperones Atx1, Atox1, and related proteins: detection probes and affinity standards.
Xiao Z; Brose J; Schimo S; Ackland SM; La Fontaine S; Wedd AG
J Biol Chem; 2011 Apr; 286(13):11047-55. PubMed ID: 21258123
[TBL] [Abstract][Full Text] [Related]
22. Metal binding domains 3 and 4 of the Wilson disease protein: solution structure and interaction with the copper(I) chaperone HAH1.
Banci L; Bertini I; Cantini F; Rosenzweig AC; Yatsunyk LA
Biochemistry; 2008 Jul; 47(28):7423-9. PubMed ID: 18558714
[TBL] [Abstract][Full Text] [Related]
23. Characterization of the interaction between the Wilson and Menkes disease proteins and the cytoplasmic copper chaperone, HAH1p.
Larin D; Mekios C; Das K; Ross B; Yang AS; Gilliam TC
J Biol Chem; 1999 Oct; 274(40):28497-504. PubMed ID: 10497213
[TBL] [Abstract][Full Text] [Related]
24. Structural basis for copper transfer by the metallochaperone for the Menkes/Wilson disease proteins.
Wernimont AK; Huffman DL; Lamb AL; O'Halloran TV; Rosenzweig AC
Nat Struct Biol; 2000 Sep; 7(9):766-71. PubMed ID: 10966647
[TBL] [Abstract][Full Text] [Related]
25. Interdomain interactions modulate collective dynamics of the metal-binding domains in the Wilson disease protein.
Rodriguez-Granillo A; Crespo A; Wittung-Stafshede P
J Phys Chem B; 2010 Feb; 114(5):1836-48. PubMed ID: 20078131
[TBL] [Abstract][Full Text] [Related]
26. Copper-mediated homo-dimerisation for the HAH1 metallochaperone.
Tanchou V; Gas F; Urvoas A; Cougouluègne F; Ruat S; Averseng O; Quéméneur E
Biochem Biophys Res Commun; 2004 Dec; 325(2):388-94. PubMed ID: 15530404
[TBL] [Abstract][Full Text] [Related]
27. The different intermolecular interactions of the soluble copper-binding domains of the menkes protein, ATP7A.
Banci L; Bertini I; Cantini F; Della-Malva N; Migliardi M; Rosato A
J Biol Chem; 2007 Aug; 282(32):23140-6. PubMed ID: 17545667
[TBL] [Abstract][Full Text] [Related]
28. Enthalpy-entropy compensation at play in human copper ion transfer.
Niemiec MS; Dingeldein AP; Wittung-Stafshede P
Sci Rep; 2015 May; 5():10518. PubMed ID: 26013029
[TBL] [Abstract][Full Text] [Related]
29. Cisplatin binds human copper chaperone Atox1 and promotes unfolding in vitro.
Palm ME; Weise CF; Lundin C; Wingsle G; Nygren Y; Björn E; Naredi P; Wolf-Watz M; Wittung-Stafshede P
Proc Natl Acad Sci U S A; 2011 Apr; 108(17):6951-6. PubMed ID: 21482801
[TBL] [Abstract][Full Text] [Related]
30. Mechanistic and Structural Basis for Inhibition of Copper Trafficking by Platinum Anticancer Drugs.
Lasorsa A; Nardella MI; Rosato A; Mirabelli V; Caliandro R; Caliandro R; Natile G; Arnesano F
J Am Chem Soc; 2019 Jul; 141(30):12109-12120. PubMed ID: 31283225
[TBL] [Abstract][Full Text] [Related]
31. Copper chaperone Atox1 interacts with the metal-binding domain of Wilson's disease protein in cisplatin detoxification.
Dolgova NV; Nokhrin S; Yu CH; George GN; Dmitriev OY
Biochem J; 2013 Aug; 454(1):147-56. PubMed ID: 23751120
[TBL] [Abstract][Full Text] [Related]
32. An NMR study of the interaction of the N-terminal cytoplasmic tail of the Wilson disease protein with copper(I)-HAH1.
Banci L; Bertini I; Cantini F; Massagni C; Migliardi M; Rosato A
J Biol Chem; 2009 Apr; 284(14):9354-60. PubMed ID: 19181666
[TBL] [Abstract][Full Text] [Related]
33. Metal binding affinities of Arabidopsis zinc and copper transporters: selectivities match the relative, but not the absolute, affinities of their amino-terminal domains.
Zimmermann M; Clarke O; Gulbis JM; Keizer DW; Jarvis RS; Cobbett CS; Hinds MG; Xiao Z; Wedd AG
Biochemistry; 2009 Dec; 48(49):11640-54. PubMed ID: 19883117
[TBL] [Abstract][Full Text] [Related]
34. Chaperone-mediated Cu+ delivery to Cu+ transport ATPases: requirement of nucleotide binding.
González-Guerrero M; Hong D; Argüello JM
J Biol Chem; 2009 Jul; 284(31):20804-11. PubMed ID: 19525226
[TBL] [Abstract][Full Text] [Related]
35. Independent evolution of heavy metal-associated domains in copper chaperones and copper-transporting atpases.
Jordan IK; Natale DA; Koonin EV; Galperin MY
J Mol Evol; 2001 Dec; 53(6):622-33. PubMed ID: 11677622
[TBL] [Abstract][Full Text] [Related]
36. Copper transporting P-type ATPases and human disease.
Cox DW; Moore SD
J Bioenerg Biomembr; 2002 Oct; 34(5):333-8. PubMed ID: 12539960
[TBL] [Abstract][Full Text] [Related]
37. Biochemical characterization of CopA, the Escherichia coli Cu(I)-translocating P-type ATPase.
Fan B; Rosen BP
J Biol Chem; 2002 Dec; 277(49):46987-92. PubMed ID: 12351646
[TBL] [Abstract][Full Text] [Related]
38. An expanding range of functions for the copper chaperone/antioxidant protein Atox1.
Hatori Y; Lutsenko S
Antioxid Redox Signal; 2013 Sep; 19(9):945-57. PubMed ID: 23249252
[TBL] [Abstract][Full Text] [Related]
39. The mechanism of Cu+ transport ATPases: interaction with CU+ chaperones and the role of transient metal-binding sites.
Padilla-Benavides T; McCann CJ; Argüello JM
J Biol Chem; 2013 Jan; 288(1):69-78. PubMed ID: 23184962
[TBL] [Abstract][Full Text] [Related]
40. Lysine-60 in copper chaperone Atox1 plays an essential role in adduct formation with a target Wilson disease domain.
Hussain F; Rodriguez-Granillo A; Wittung-Stafshede P
J Am Chem Soc; 2009 Nov; 131(45):16371-3. PubMed ID: 19863064
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
